BlackRock Investment Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9.74M Buy
12,185
+286
+2% +$227K 0.01% 1131
2016
Q3
$10.4M Buy
11,899
+563
+5% +$408K 0.01% 984
2016
Q2
$6.36M Buy
11,336
+10,294
+988% +$5.83M 0.01% 1269
2016
Q1
$574K Sell
1,042
-300
-22% -$184K ﹤0.01% 2833
2015
Q4
$1.12M Sell
1,342
-12
-0.9% -$12K ﹤0.01% 2519
2015
Q3
$1.5M Sell
1,354
-301
-18% -$549K ﹤0.01% 2285
2015
Q2
$3.61M Sell
1,655
-4,153
-72% -$8.46M ﹤0.01% 1753
2015
Q1
$9.09M Buy
5,808
+725
+14% +$957K 0.01% 1007
2014
Q4
$6.04M Sell
5,083
-36
-0.7% -$24.1K 0.01% 1235
2014
Q3
$2.38M Buy
5,119
+638
+14% +$294K ﹤0.01% 1874
2014
Q2
$2.24M Buy
4,481
+2,948
+192% +$945K ﹤0.01% 1998
2014
Q1
$452K Buy
1,533
+78
+5% +$23.6K ﹤0.01% 3007
2013
Q4
$395K Buy
1,455
+4
+0.3% +$1.12K ﹤0.01% 3062
2013
Q3
$507K Buy
+1,451
New +$539K ﹤0.01% 2924

Other funds holding BLUE

BlackRock Investment Management's BLUE Position: Q4 2016 in Review

BlackRock Investment Management increased its bluebird bio (BLUE) stake by 2.4% in Q4 2016, buying an estimated $227K and bringing the position to 12,185 shares worth $9.74M. The position accounts for 0.01% of the portfolio, ranked #1131.

BlackRock Investment Management first reported a position in BLUE in Q3 2013 and has held it in 14 quarters since. The position peaked at $10.4M in Q3 2016. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

  • BlackRock Investment Management held 12,185 shares of bluebird bio worth $9.74M as of Q4 2016.
  • BlackRock Investment Management bought 286 bluebird bio shares in Q4 2016, an estimated $227K.
  • bluebird bio made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1131 holding.
  • BlackRock Investment Management first reported a position in bluebird bio in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Investment Management's bluebird bio position peaked at $10.4M in Q3 2016.
  • 199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.